{"id":"MTBKS214","research":"hum0372","url":"https://humandbs.dbcls.jp/dataset/MTBKS214","datePublished":"2022-11-02","dateModified":"2022-11-04","values":[{"key":"access-criteria","label":{"ja":"アクセス制限","en":"Access criteria"},"type":"vocabulary","terms":[{"code":"unrestricted-access","label":{"ja":"非制限公開","en":"Unrestricted-access"}}]},{"key":"type-of-data","label":{"ja":"データの種類","en":"Type of data"},"type":"text","text":{"ja":"364代謝物の要約統計量","en":"the summary statistics"}}],"experiments":[{"label":"メタボローム (CE-TOFMS / LC-TOFMS)","values":[{"key":"materials-and-participants","label":{"ja":"材料と対象者","en":"Materials and participants"},"type":"text","text":{"ja":"2型糖尿病・合併症なし（ICD10：E11）：159症例\n糖尿病性腎臓病と糖尿病性網膜症の両方を合併する2型糖尿病（ICD10：E11）：141症例","en":"T2D without diabetic complications (ICD10: E11): 159 cases\nT2D with both diabetic kidney disease and diabetic retinopathy (ICD10: E11): 141 cases"}},{"key":"disease","label":{"ja":"疾患","en":"Disease"},"type":"disease","diseases":[{"terms":[{"code":"E11","label":{"ja":"２型＜インスリン非依存性＞糖尿病＜NIDDM＞","en":"Type 2 diabetes mellitus"}}],"name":{"ja":"2型糖尿病・合併症なし","en":"T2D without diabetic complications"}},{"terms":[{"code":"E11","label":{"ja":"２型＜インスリン非依存性＞糖尿病＜NIDDM＞","en":"Type 2 diabetes mellitus"}}],"name":{"ja":"糖尿病性腎臓病と糖尿病性網膜症の両方を合併する2型糖尿病","en":"T2D with both diabetic kidney disease and diabetic retinopathy"}}]},{"key":"health-status","label":{"ja":"健康状態","en":"Health status"},"type":"vocabulary","terms":[{"code":"affected","label":{"ja":"罹患","en":"Affected"}}]},{"key":"subject-count","label":{"ja":"対象者数","en":"Subject count"},"type":"number","numbers":[{"value":300,"unit":null,"high":null}]},{"key":"subject-count-type","label":{"ja":"対象者数の数え方","en":"Counted as"},"type":"vocabulary","terms":[{"code":"individual","label":{"ja":"人数","en":"Individual"}}]},{"key":"sample-description","label":{"ja":"試料説明","en":"Sample description"},"type":"text","text":{"ja":"血清サンプル","en":"Serum"}},{"key":"tissue","label":{"ja":"組織","en":"Tissue"},"type":"vocabulary","terms":[{"code":"serum","label":{"ja":"血清","en":"Serum"}}]},{"key":"is-tumor","label":{"ja":"腫瘍 / 非腫瘍","en":"Tumor / normal"},"type":"vocabulary","terms":[{"code":"normal","label":{"ja":"非腫瘍","en":"Normal"}}]},{"key":"sample-provider","label":{"ja":"試料の入手元","en":"Sample provider"},"type":"text","text":{"ja":null,"en":null}},{"key":"experimental-method","label":{"ja":"実験方法","en":"Experimental method"},"type":"vocabulary","terms":[{"code":"metabolomics","label":{"en":"Metabolomics"}}]},{"key":"targets","label":{"ja":"測定対象","en":"Target"},"type":"text","text":{"ja":"364代謝物","en":"364 serum metabolites"}},{"key":"platform","label":{"ja":"プラットフォーム","en":"Platform"},"type":"vocabulary","terms":[{"code":"agilent-ce-system-equipped-with-an-agilent-6210-tofms","label":{"en":"Agilent CE system equipped with an Agilent 6210 TOFMS"}},{"code":"agilent-1100-isocratic-hplc-pump","label":{"en":"Agilent 1100 isocratic HPLC pump"}},{"code":"agilent-lc-system-equipped-with-an-agilent-6230-tofms","label":{"en":"Agilent LC System equipped with an Agilent 6230 TOFMS"}}]},{"key":"measurement-conditions","label":{"ja":"測定条件","en":"Measurement condition"},"type":"text","text":{"ja":null,"en":null}},{"key":"normalization","label":{"ja":"正規化","en":"Normalization"},"type":"text","text":{"ja":null,"en":null}},{"key":"analysis-methods","label":{"ja":"解析方法","en":"Analysis method"},"type":"text","text":{"ja":null,"en":null}},{"key":"has-phenotype-data","label":{"ja":"表現型データの有無","en":"Phenotype data"},"type":"vocabulary","terms":[{"code":"included","label":{"ja":"あり","en":"Included"}}]},{"key":"data-summary","label":{"ja":"データ概要","en":"Data summary"},"type":"text","text":{"ja":"LC-MS","en":"LC-MS"}},{"key":"policies","label":{"ja":"利用ポリシー","en":"Data use policy"},"type":"vocabulary","terms":[{"code":"nbdc-data-sharing-policy-jgap000001","label":{"ja":"NBDC データ共有ポリシー (JGAP000001)","en":"NBDC data sharing policy (JGAP000001)"}}]}]}],"dataVolume":59341,"fileFormats":[{"code":"tsv","label":{"en":"TSV"}}]}